Skip to main content
. 2022 Mar 16;17(3):e0265427. doi: 10.1371/journal.pone.0265427

Fig 2. 18F-FSPG SUVmax correlation with xCT (spearman correlation 0.440, p = 0.153) and CD44 (spearman correlation 0.172, p = 0.594) in cancer cases.

Fig 2